Boston Trust Walden Corp Purchases 19,579 Shares of Axcelis Technologies, Inc. $ACLS

Boston Trust Walden Corp raised its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 2.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 845,911 shares of the semiconductor company’s stock after acquiring an additional 19,579 shares during the quarter. Boston Trust Walden Corp’s holdings in Axcelis Technologies were worth $58,952,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB grew its holdings in Axcelis Technologies by 50.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 481 shares of the semiconductor company’s stock valued at $34,000 after purchasing an additional 161 shares during the period. Parallel Advisors LLC grew its holdings in Axcelis Technologies by 129.0% during the second quarter. Parallel Advisors LLC now owns 545 shares of the semiconductor company’s stock valued at $38,000 after purchasing an additional 307 shares during the period. Fifth Third Bancorp grew its holdings in Axcelis Technologies by 160.5% during the first quarter. Fifth Third Bancorp now owns 581 shares of the semiconductor company’s stock valued at $29,000 after purchasing an additional 358 shares during the period. Bayforest Capital Ltd bought a new position in Axcelis Technologies during the first quarter valued at $38,000. Finally, Nisa Investment Advisors LLC grew its holdings in Axcelis Technologies by 97.5% during the first quarter. Nisa Investment Advisors LLC now owns 796 shares of the semiconductor company’s stock valued at $40,000 after purchasing an additional 393 shares during the period. 89.98% of the stock is owned by institutional investors.

Axcelis Technologies Trading Up 2.8%

NASDAQ:ACLS opened at $81.43 on Tuesday. The company has a market cap of $2.56 billion, a P/E ratio of 16.65 and a beta of 1.75. The stock’s fifty day moving average price is $85.35 and its two-hundred day moving average price is $69.46. Axcelis Technologies, Inc. has a 1 year low of $40.40 and a 1 year high of $107.23. The company has a debt-to-equity ratio of 0.04, a current ratio of 6.01 and a quick ratio of 4.26.

Axcelis Technologies (NASDAQ:ACLS) last posted its earnings results on Monday, April 21st. The semiconductor company reported $1.71 earnings per share (EPS) for the quarter. Axcelis Technologies had a return on equity of 16.26% and a net margin of 17.69%.The firm had revenue of $252.42 million for the quarter. As a group, analysts expect that Axcelis Technologies, Inc. will post 2.55 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ACLS. Bank of America lowered Axcelis Technologies from a “neutral” rating to an “underperform” rating and increased their price objective for the company from $81.00 to $90.00 in a report on Monday. Weiss Ratings reissued a “hold (c)” rating on shares of Axcelis Technologies in a report on Wednesday, October 8th. Wall Street Zen upgraded Axcelis Technologies from a “hold” rating to a “buy” rating in a research report on Saturday. Zacks Research downgraded Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Finally, B. Riley increased their target price on Axcelis Technologies from $58.00 to $75.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 18th. Three research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $97.00.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.